Related Experiment Video
Updated: Mar 26, 2026
07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
Multiwalled Carbon Nanotubes Inhibit Tumor Progression in a Mouse Model
Lorena García-Hevia1, Juan C Villegas1, Fidel Fernández1
1Grupo de Nanomedicina-IDIVAL, Universidad de Cantabria, Santander, 39011, Spain.
Advanced Healthcare Materials
|February 12, 2016
Summary
Malignant melanoma tumors treated with multiwalled carbon nanotubes (MWCNTs) showed significant anti-tumoral effects. These effects persisted even in paclitaxel-resistant cancer cells, offering new hope for cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Cancer Research
Background:
- Multiwalled carbon nanotubes (MWCNTs) are investigated for nanomedicine and cancer therapy.
- MWCNTs can interact with cellular structures like the cytoskeleton, affecting cell division.
Purpose of the Study:
- To investigate the in vivo anti-tumoral effects of MWCNTs.
- To evaluate MWCNT efficacy against paclitaxel-resistant melanoma cells.
Main Methods:
- In vivo studies using solid malignant melanomas induced by allograft transplantation.
- Assessment of MWCNT anti-tumoral activity in paclitaxel-resistant cancer models.
Main Results:
- MWCNTs demonstrated significant anti-tumoral effects in vivo.
- The anti-tumoral efficacy of MWCNTs was maintained in paclitaxel-resistant melanomas.
Conclusions:
- MWCNTs show promise as a therapeutic agent against solid tumors.
- MWCNTs may offer a novel strategy to overcome drug resistance in cancer treatment.
